Volume 26, Number 2—February 2020
Chronic Human Pegivirus 2 without Hepatitis C Virus Co-infection
|Finding||HCV negative, n = 3||HCV positive, n = 2||p value|
|Average HPgV-2, log10 copies/mL|
|Average years injection drug use†||5.5||7.9||NA|
|Average age at detection of HPgV-2 RNA, y†||25.6||26.1||NA|
*HCV, hepatitis C virus; HPgV-2, human pegivirus 2; NS, nonstructural protein.
†No p values available because of low number of samples.
Page created: January 17, 2020
Page updated: January 17, 2020
Page reviewed: January 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.